Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.

ABSTRACT:

Background and aims

Physician and pharmacist collaboration may help address the shortage of buprenorphine-waivered physicians and improve care for patients with opioid use disorder (OUD). This study investigated the feasibility and acceptability of a new collaborative care model involving buprenorphine-waivered physicians and community pharmacists.

Design

Nonrandomized, single-arm, open-label feasibility trial.

Setting

Three office-based buprenorphine treatment (OBBT) clinics and three community pharmacies in the United States.

Participants

Six physicians, six pharmacists, and 71 patients aged ≥18 years with Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) OUD on buprenorphine maintenance.

Intervention

After screening, eligibl

SUBMITTER: Wu LT 

PROVIDER: S-EPMC8172420 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature